173 related articles for article (PubMed ID: 14737106)
1. C/EBPalphap30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding.
Cleaves R; Wang QF; Friedman AD
Oncogene; 2004 Jan; 23(3):716-25. PubMed ID: 14737106
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle inhibition mediated by the outer surface of the C/EBPalpha basic region is required but not sufficient for granulopoiesis.
Wang QF; Cleaves R; Kummalue T; Nerlov C; Friedman AD
Oncogene; 2003 May; 22(17):2548-57. PubMed ID: 12730669
[TBL] [Abstract][Full Text] [Related]
3. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
[TBL] [Abstract][Full Text] [Related]
4. CCAAT/enhancer binding protein alpha (C/EBPalpha) and C/EBPalpha myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-kappaB p50.
Paz-Priel I; Cai DH; Wang D; Kowalski J; Blackford A; Liu H; Heckman CA; Gombart AF; Koeffler HP; Boxer LM; Friedman AD
Mol Cancer Res; 2005 Oct; 3(10):585-96. PubMed ID: 16254192
[TBL] [Abstract][Full Text] [Related]
5. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
[TBL] [Abstract][Full Text] [Related]
6. ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha.
Gombart AF; Grewal J; Koeffler HP
J Leukoc Biol; 2007 Jun; 81(6):1535-47. PubMed ID: 17347301
[TBL] [Abstract][Full Text] [Related]
7. GADD153/CHOP, a DNA damage-inducible protein, reduced CAAT/enhancer binding protein activities and increased apoptosis in 32D c13 myeloid cells.
Friedman AD
Cancer Res; 1996 Jul; 56(14):3250-6. PubMed ID: 8764117
[TBL] [Abstract][Full Text] [Related]
8. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
9. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
Pabst T; Mueller BU; Zhang P; Radomska HS; Narravula S; Schnittger S; Behre G; Hiddemann W; Tenen DG
Nat Genet; 2001 Mar; 27(3):263-70. PubMed ID: 11242107
[TBL] [Abstract][Full Text] [Related]
10. Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction.
Rangatia J; Vangala RK; Singh SM; Peer Zada AA; Elsässer A; Kohlmann A; Haferlach T; Tenen DG; Hiddemann W; Behre G
Oncogene; 2003 Jul; 22(30):4760-4. PubMed ID: 12879022
[TBL] [Abstract][Full Text] [Related]
11. p21Waf1 inhibits granulocytic differentiation of 32Dcl3 cells.
Ghanem L; Steinman RA
Leuk Res; 2006 Oct; 30(10):1285-92. PubMed ID: 16499966
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor.
Wang QF; Friedman AD
Blood; 2002 Apr; 99(8):2776-85. PubMed ID: 11929766
[TBL] [Abstract][Full Text] [Related]
13. Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein alpha.
Friedman AD; Keefer JR; Kummalue T; Liu H; Wang QF; Cleaves R
Blood Cells Mol Dis; 2003; 31(3):338-41. PubMed ID: 14636649
[TBL] [Abstract][Full Text] [Related]
14. Identification of the C/EBPα C-terminal tail residues involved in the protein interaction with GABP and their potency in myeloid differentiation of K562 cells.
Shimokawa T; Nunomura S; Fujisawa D; Ra C
Biochim Biophys Acta; 2013 Nov; 1829(11):1207-17. PubMed ID: 24076158
[TBL] [Abstract][Full Text] [Related]
15. Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage.
Porse BT; Bryder D; Theilgaard-Mönch K; Hasemann MS; Anderson K; Damgaard I; Jacobsen SE; Nerlov C
J Exp Med; 2005 Jul; 202(1):85-96. PubMed ID: 15983063
[TBL] [Abstract][Full Text] [Related]
16. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription.
Thiel G; Al Sarraj J; Vinson C; Stefano L; Bach K
J Neurochem; 2005 Jan; 92(2):321-36. PubMed ID: 15663480
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of granulocyte and monocyte development.
Friedman AD
Oncogene; 2002 May; 21(21):3377-90. PubMed ID: 12032776
[TBL] [Abstract][Full Text] [Related]
18. Granulopoiesis requires increased C/EBPα compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells.
Ma O; Hong S; Guo H; Ghiaur G; Friedman AD
PLoS One; 2014; 9(4):e95784. PubMed ID: 24752325
[TBL] [Abstract][Full Text] [Related]
19. C/EBPalphap30 plays transcriptional regulatory roles distinct from C/EBPalphap42.
Wang C; Chen X; Wang Y; Gong J; Hu G
Cell Res; 2007 Apr; 17(4):374-83. PubMed ID: 17242690
[TBL] [Abstract][Full Text] [Related]
20. Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPalpha by inhibiting its ubiquitination.
Trivedi AK; Bararia D; Christopeit M; Peerzada AA; Singh SM; Kieser A; Hiddemann W; Behre HM; Behre G
Oncogene; 2007 Mar; 26(12):1789-801. PubMed ID: 16983342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
